|
PTGR2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.702200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.686200E-02 |
| Normal-vs-Stage2 |
2.556700E-03 |
| Normal-vs-Stage3 |
6.838800E-04 |
| Normal-vs-Stage4 |
1.814160E-02 |
| Stage1-vs-Stage2 |
1.092400E-01 |
| Stage1-vs-Stage3 |
1.874360E-02 |
| Stage1-vs-Stage4 |
2.037800E-01 |
| Stage2-vs-Stage3 |
6.386000E-01 |
| Stage2-vs-Stage4 |
9.114000E-01 |
| Stage3-vs-Stage4 |
7.948200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.651800E-02 |
| Normal-vs-AfricanAmerican |
7.811900E-04 |
| Normal-vs-Asian |
5.636200E-03 |
| Caucasian-vs-AfricanAmerican |
8.102600E-03 |
| Caucasian-vs-Asian |
4.364400E-02 |
| AfricanAmerican-vs-Asian |
7.516500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.438250E-02 |
| Normal-vs-Female |
5.875500E-03 |
| Male-vs-Female |
1.253450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.130000E-02 |
| Normal-vs-Extreme_Weight |
4.490200E-02 |
| Normal-vs-Obese |
1.249790E-02 |
| Normal-vs-Extreme_Obese |
1.477030E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.769400E-01 |
| Normal_Weight-vs-Obese |
6.443400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.184600E-01 |
| Extreme_Weight-vs-Obese |
9.919000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.923600E-01 |
| Obese-vs-Extreme_Obese |
8.562200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.015190E-01 |
| Normal-vs-Age(41-60Yrs) |
2.933800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.038460E-02 |
| Normal-vs-Age(81-100Yrs) |
2.144400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.347400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.742400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.086400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.215800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.872400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.796400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.045610E-01 |
| Normal-VS-Type2 PRCC |
3.91459999999899E-05 |
| Normal-VS-KIRP CIMP |
1.923810E-02 |
| Normal-VS-Unclassified PRCC |
2.222700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.07340000005318E-07 |
| Type1 PRCC-VS-KIRP CIMP |
2.558400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.761300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
9.160400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.383800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.186600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.558270E-03 |
| Normal-vs-N1 |
1.356000E-02 |
| Normal-vs-N2 |
1.697570E-02 |
| N0-vs-N1 |
8.673400E-01 |
| N0-vs-N2 |
1.337580E-01 |
| N1-vs-N2 |
1.068230E-01 |
|
|
